Open access · CC-BY
via OpenAlex
Spermidine enhances the efficacy of adjuvant in HBV vaccination in mice
Daisuke Ito, Hiroyasu Ito, Tatsuya Ando, Yasuhiro Sakai, Takayasu Ideta, Ken J. Ishii, Tetsuya Ishikawa, Masahito Shimizu
Hepatology Communications · 2023 · ▲ 3 citations
Abstract
Background: Various vaccine adjuvants have been developed to eliminate HBV from patients with chronic HBV infection. In addition, spermidine (SPD), a type of polyamine, has been reported to enhance the activity of immune cells. In the present study, we investigated whether the combination of SPD and vaccine adjuvant enhances the HBV antigen-specific immune response to HBV vaccination. Methods: Wild-type and HBV-transgenic (HBV-Tg) mice were vaccinated 2 or 3 times. SPD was orally administered in drinking water. Cyclic guanosine monophosphate-AMP (cGAMP) and nanoparticulate CpG-ODN (K3-SPG) were used as the HBV vaccine adjuvants. The HBV antigen-specific immune response was evaluated by measuring the HBsAb titer in blood collected over time and the number of interferon-γ producing cells by enzyme-linked immunospot assay. Results: The administration of HBsAg + cGAMP + SPD or HBsAg + K3-SPG + SPD significantly enhanced HBsAg-specific interferon-γ production by CD8 T cells from wild-type and HBV-Tg mice. The administration of HBsAg, cGAMP, and SPD increased serum HBsAb levels in wild-type and HBV-Tg mice. In HBV-Tg mice, the administration of SPD + cGAMP or SPD + K3-SPG with HBV vaccination significantly reduced HBsAg levels in the liver and serum. CONCLUSIONS: These results indicate that the combination of HBV vaccine adjuvant and SPD induces a stronger humoral and cellular immune response through T-cell activation. These treatments may support the development of a strategy to completely eliminate HBV.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1097/hc9.0000000000000104
- Canonical
- link ↗
- Fetched
- 2026-10-31 MST
Cite this
APA
Ito, D., Ito, H., Ando, T., Sakai, Y., Ideta, T., Ishii, K.J., Ishikawa, T., & Shimizu, M. (2023). Spermidine enhances the efficacy of adjuvant in HBV vaccination in mice. <em>Hepatology Communications</em>. https://doi.org/10.1097/hc9.0000000000000104
Vancouver
Ito D, Ito H, Ando T, Sakai Y, Ideta T, Ishii KJ, et al. Spermidine enhances the efficacy of adjuvant in HBV vaccination in mice. Hepatology Communications. 2023. doi:10.1097/hc9.0000000000000104.
BibTeX
@article{daisuke2023Spermi,
title = {Spermidine enhances the efficacy of adjuvant in HBV vaccination in mice},
author = {Daisuke Ito and Hiroyasu Ito and Tatsuya Ando and Yasuhiro Sakai and Takayasu Ideta and Ken J. Ishii and Tetsuya Ishikawa and Masahito Shimizu},
journal = {Hepatology Communications},
year = {2023},
doi = {10.1097/hc9.0000000000000104},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
eLife 2014
Open access · CC-BY
Autophagy is a critical regulator of memory CD8+ T cell formation
Ageing Research Reviews 2016
Preprint · OA
Regenerative function of immune system: Modulation of muscle stem cells
Nature Communications 2016
Open access · CC-BY
Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination
Gut 2021
Open access · CC-BY
PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF
Biogerontology 2025
Open access · CC-BY
Neuroinflammaging and the Immune Landscape: The Role of Autophagy and Senescence in Aging Brain
Redox Biology 2014
Open access · CC-BY